FLECTOR Drug Patents & Exclusivity Expiration

INSTITUT BIOCHEMIQUE SA

FLECTOR (diclofenac epolamine) is an FDA-approved drug whose original license was filed by INSTITUT BIOCHEMIQUE SA. There are 1 patents protecting this drug of which 0 are expired.

Drug Applications

Patents

Patent #PatentExpiration

5607690

(in 1822 days)

Exclusivity

There are no exclusivities.